Boehringer Ingelheim's sales in Spain grow more than 10% in 2025

The business of the German pharmaceutical company Boehringer Ingelheim in Spain grew by 10.1% in 2025, to 1,005 million euros. The company's general manager in the State, Nicolas Dumoulin, has assured that the results of the last fiscal year -- presented this Thursday -- are "good".